![](/img/cover-not-exists.png)
An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial
Mark P. Connolly, Sandy K. Nielsen, Craig J. Currie, Chris D. Poole, Simon P.L. TravisVolume:
3
Year:
2009
Language:
english
DOI:
10.1016/j.crohns.2008.10.004
File:
PDF, 188 KB
english, 2009